Medical News

RSS

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Advancing research on drug-eluting balloons for the treatment of coronary and peripheral artery disease, Medtronic, Inc., today announced the latest results from the IN.PACT drug-eluting balloon (DEB) clinical program presented last week at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference.

29 Sep 2010

Study links noise and stochastic resonance to higher cognitive functions and attention

Playing white noise in class can help inattentive children learn. Researchers writing in BioMed Central's open access journal Behavioral and Brain Functions tested the effect of the meaningless random noise on a group of 51 schoolchildren, finding that although it hindered the ability of those who normally pay attention, it improved the memory of those that had difficulties in paying attention.

29 Sep 2010

Neurons that control sexual behavior mapped

How the bundles of neurons in the brain controls behaviour remains an ongoing mystery. Researchers from the Institute of Molecular Pathology (IMP), in Vienna, Austria, and the Laboratory of Molecular Biology (LMB/MRC), Cambridge, United Kingdom, have mapped neurons of the fruit fly, Drosophila, that controls sexual behavior. "We literally untangled the mess of wires in the fly brain and laid the ground plans for investigating a complex behavior in a simple organism," says Jai Yu, whose doctoral work is published in Current Biology.

29 Sep 2010

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

GeneGo, Inc., the leading systems biology tools company and Omicsoft Corporation, the leader in the OMIC repository and analysis field, announced today integration of Omicsoft's Next Generation Sequencing tools with GeneGo's MetaCore data mining suite.

29 Sep 2010

Centric Health acquires two pharmacies on Southlake Regional Health Centre campus in Ontario

Centric Health Corporation, Canada's leading diversified healthcare company, today announced that it has acquired, in partnership, two pharmacies located on the Southlake Regional Health Centre campus in Newmarket, Ontario.

29 Sep 2010

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Benrikal Services to distribute the Bengal Radial Compression Band in the United States.

29 Sep 2010

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

TeleHealth Services, the nation's leading provider of healthcare-grade televisions and interactive patient education solutions, today announced an extension of a seven year partnership with St. Vincent's HealthCare (SVHC) to further enhance the hospital's patient education initiatives. The health system will utilize TeleHealth's technology in St. Vincent's Medical Center and new addition, St. Luke's Hospital.

29 Sep 2010

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Ligon Discovery, the innovator of Small Molecule Microarray technology, today announced that it has partnered with Bayer Schering Pharma AG, Germany, to apply its proprietary Small Molecule Microarray screening platform (SMM) to discover potential first-in-class drug candidates for new disease targets.

29 Sep 2010

Pulmokine receives NIH SBIR grants to develop novel treatments for PAH

YM BioSciences Inc., today reported that Pulmokine Inc. (Slingerlands, New York), a licensee of several small molecule compounds from YM, has been awarded two National Institutes of Health (NIH) Small Business Innovation Research (SBIR) grants. The grants, totaling more than US$650,000, are Phase I awards to develop novel treatments for Pulmonary Arterial Hypertension (PAH).

29 Sep 2010

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

Quick-Med Technologies, Inc.a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today its NIMBUS and Stay Fresh antimicrobial technologies will be highlighted at the 2010 Clinical Symposium on Advances in Skin and Wound Care, to be held in Orlando, Florida from September 30 – October 3, 2010.

29 Sep 2010

New program offers options for fertility preservation in children with cancer

It is estimated that 1 in 500 children will be diagnosed with a form of childhood cancer. Fortunately, with the use of aggressive treatment modalities, more than 75% of these children will be cured. Therefore, many of these children and parents are looking beyond the cancer at important quality of life issues and guiding their treatments to assure "normal" post-cancer survivorship.

29 Sep 2010

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.

29 Sep 2010

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

Quidel Corporation, a leading provider of rapid diagnostic testing solutions, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of its QuickVue RSV 10, a lateral flow immunoassay test for the qualitative detection of acute respiratory syncytial virus (RSV) infections.

29 Sep 2010

First Edition: September 29, 2010

In today's headlines, reports about the continuing politics surrounding the health overhaul, as both parties vie for the loyalty of older voters and First Lady Michelle Obama steps up efforts to promote the new law.

29 Sep 2010

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a Phase I study, called RV262, recently began to evaluate a combination DNA prime/MVA vector boost regimen that was developed to protect against diverse subtypes of HIV-1 prevalent in North America, Europe, Africa, and South America.

29 Sep 2010

Significant progress made universally in increasing access to HIV/AIDS services: Report

Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.

29 Sep 2010

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, today released highlights from a new survey that reveals researchers around the globe are not only ready for the next phase in search and discovery, but also prepared to actively contribute to making it a reality.

29 Sep 2010

Cancer-causing mutations have minimum effect on tumor growth: Research

Individual cancer causing mutations have a minute effect on tumor growth, increasing the rate of cell division by just 0.4 percent on average, according to new mathematical modeling by scientists at Harvard University, Johns Hopkins University, and other institutions.

29 Sep 2010

Report shows continuing progress in scaling up global HIV/AIDS interventions

The 2010 report on universal access to HIV prevention, care and treatment released today by WHO, UNAIDS, and UNICEF shows continuing progress in scaling up global HIV/AIDS interventions.

29 Sep 2010

Sysmex to supply medical hematology analyzers to USAMMA

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced that the company has been awarded a BPA Equipment purchase contract agreement. The contract was issued by USA Medical Research ACQ Activity for the U.S. Army Medical Material Agency (USAMMA).

From Sysmex America, Inc. 29 Sep 2010

Medical News

IN.PACT drug-eluting balloons show promising results for superficial femoral artery disease treatment

Study links noise and stochastic resonance to higher cognitive functions and attention

Neurons that control sexual behavior mapped

Omicsoft's Next Generation Sequencing tools integrated with GeneGo's MetaCore data mining suite

Centric Health acquires two pharmacies on Southlake Regional Health Centre campus in Ontario

AccessClosure enters agreement with Benrikal Services for Bengal Radial Compression Band distribution

TeleHealth Services extends partnership with SVHC to enhance patient education initiatives

Bayer Schering collaborates with Ligon to apply SMM technology for first-in-class drug discovery

Pulmokine receives NIH SBIR grants to develop novel treatments for PAH

Quick-Med to present abstracts on antimicrobial technologies at Clinical Symposium

New program offers options for fertility preservation in children with cancer

XOMA completes patient enrollment in XOMA 052 Phase 2a trial

Quidel receives FDA clearance for QuickVue RSV 10 immunoassay test

First Edition: September 29, 2010

NIH trial selects Inovio's PENNVAX-G DNA vaccine candidate to evaluate HIV-1 prevalent

Significant progress made universally in increasing access to HIV/AIDS services: Report

Researchers primed to contribute next phase in search and discovery: Elsevier survey

Cancer-causing mutations have minimum effect on tumor growth: Research

Report shows continuing progress in scaling up global HIV/AIDS interventions

Sysmex to supply medical hematology analyzers to USAMMA

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News